Coronavirus (COVID-19) updates for UC San Diego Health patients and visitors. Learn More

Menu
Search

UCSD Cardiologist Receives NIH New Innovator Award

 

October 08, 2010  |  

The National Institutes of Health has chosen Neil Chi, MD, PhD, assistant professor of medicine in the division of cardiology at the University of California, San Diego, as one of its 2010 NIH Director’s New Innovator Award recipients.

With this $2.3 million award, Chi and his team will study the remarkable ability of the zebrafish to regenerate the heart.  The team has created a collection of tools which will help in understanding the underlying mechanisms of cardiac regeneration.  “Heart failure is the leading cause of death in the United States,” said Dr. Chi.  “We hope to someday apply what we learn from the zebrafish heart regeneration process towards understanding how to directly reprogram human cells into ventricular cardiomyocytes for the regeneration of injured hearts from patients afflicted with heart attacks and/or heart failure.”

Chi is one of 52 New Innovator honorees nationwide, including 13 researchers from within the University of California.  "NIH is pleased to be supporting early-stage investigators from across the country who are taking considered risks in a wide range of areas in order to accelerate research," said Francis S. Collins, MD, PhD, director of the National Institutes of Health. "We look forward to the results of their work."

Established in 2007, the NIH Director's New Innovator Award funds new investigators who propose highly innovative research projects that could have an exceptionally great impact on biomedical or behavioral science.  The award program is designed to support unusually creative new investigators with highly innovative research ideas at an early stage of their career.

# # #

Media Contact: Kim Edwards, 619-543-6163, kedwards@ucsd.edu




Media Contact

Share This Article


Related News

3/26/2020
Researchers at University of California San Diego School of Medicine are launching a pair of studies to answer critical questions regarding the roles COVID-19 may play in breast milk and pregnancy.
3/24/2020
Researchers at four University of California Health medical centers have begun recruiting participants for a Phase II clinical trial to investigate the safety and efficacy of treating adult patients w ...
3/20/2020
Partnering with five diagnostics manufacturers, UC San Diego is significantly ramping up testing for COVID-19, projecting capacity to complete up to 1,500 tests daily within two to three weeks.
3/18/2020
New study finds gene therapy improved cardiac, muscle and liver function in Danon disease mouse models.



Follow Us